Cargando…
The spleen may be an important target of stem cell therapy for stroke
Stroke is the most common cerebrovascular disease, the second leading cause of death behind heart disease and is a major cause of long-term disability worldwide. Currently, systemic immunomodulatory therapy based on intravenous cells is attracting attention. The immune response to acute stroke is a...
Autores principales: | Wang, Zhe, He, Da, Zeng, Ya-Yue, Zhu, Li, Yang, Chao, Lu, Yong-Juan, Huang, Jie-Qiong, Cheng, Xiao-Yan, Huang, Xiang-Hong, Tan, Xiao-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352449/ https://www.ncbi.nlm.nih.gov/pubmed/30700305 http://dx.doi.org/10.1186/s12974-019-1400-0 |
Ejemplares similares
-
Targeting Brain-spleen Crosstalk After Stroke: New Insights Into Stroke Pathology and Treatment
por: Han, Dong, et al.
Publicado: (2021) -
Perspectives on effect of spleen in ischemic stroke
por: Ding, Yarong, et al.
Publicado: (2022) -
Activation of spleen cells by ArtinM may account for its immunomodulatory properties
por: da Silva, Thiago Aparecido, et al.
Publicado: (2014) -
Synaptosomal-associated protein 25 may be an intervention target for improving sensory and locomotor functions after spinal cord contusion
por: Zhong, Zhan-qiong, et al.
Publicado: (2017) -
De Novo Assembly of the Japanese Flounder (Paralichthys olivaceus) Spleen Transcriptome to Identify Putative Genes Involved in Immunity
por: Huang, Lin, et al.
Publicado: (2015)